US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

29.00

-0.5800-1.96%

Post-market: 29.000.00000.00%19:54 EDT

Volume:156.51K

Turnover:4.55M

Market Cap:816.24M

PE:-16.39

High:29.52

Open:28.80

Low:28.57

Close:29.58

Loading ...

Overview Company News Filings

Lightstone Ventures, Temasek’s ClavystBio co-lead Allay Therapeutics’ US$57.5 million Series D funding

Actuate Therapeutics Hosts Key Opinion Leader Event

Crispr Therapeutics call volume above normal and directionally bullish

Edgewise Therapeutics Price Target Maintained With a $48.00/Share by RBC Capital

Kazia Therapeutics says first patient dosed in Phase 1b Trial of paxalisib

Atossa Therapeutics initiated with a Buy at Craig-Hallum

Cutia Therapeutics Successfully Passes All Resolutions at AGM

Chimeric Therapeutics Receives US FDA Fast Track Designation for CHM CDH17 CAR-T Therapy

MT Newswires Live

Addex Therapeutics Advances GABAB PAM Program for Chronic Cough

Promising Developments in Mersana Therapeutics’ Emi-Le Program Bolster Positive Outlook for TNBC Treatment

Marker Therapeutics Reports Q1 2025 Financial Results

Trevi Therapeutics Announces Public Offering Pricing

ADC Therapeutics falls -4.5%

BriaCell Therapeutics Schedules Virtual Investor Presentations for June 2025

Allarity Therapeutics Announces Research Collaboration with Indiana Biosciences Research Institute to Further Advance Understanding of Stenoparib’s Unique, Dual Therapeutic Mechanism of Action

Quince Therapeutics Is Maintained at Buy by D. Boral Capital

Design Therapeutics announces first FA patient dosed in RESTORE-FA trial

Buy Recommendation for Candel Therapeutics: Promising Data on CAN-2409 Treatment for Prostate Cancer

EXACT Therapeutics to Hold Separate Board Candidate Votes at AGM

IRLAB Therapeutics to Present at Aktiedagarna Event in Stockholm

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LENZ/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":29,"timestamp":1749844800000,"preClose":29.58,"halted":0,"volume":156505,"hourTrading":{"tag":"盘后","latestPrice":29,"preClose":29,"latestTime":"19:54 EDT","volume":608,"amount":17570.81,"timestamp":1749858862399},"delay":0,"floatShares":11653723,"shares":28146154,"eps":-1.769251,"marketStatus":"Market Closed","change":-0.58,"latestTime":"06-13 16:00:00 EDT","open":28.8,"high":29.52,"low":28.565,"amount":4554492.6963,"amplitude":0.032285,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":29.58,"preHourTrading":{"tag":"盘前","latestPrice":28.84,"preClose":29.58,"latestTime":"09:29 EDT","volume":77,"amount":2235.719948,"timestamp":1749821370092},"postHourTrading":{"tag":"盘后","latestPrice":29,"preClose":29,"latestTime":"19:54 EDT","volume":608,"amount":17570.81,"timestamp":1749858862399},"volumeRatio":0.2990981094374136,"impliedVol":0.5592,"impliedVolPercentile":0.5435},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":11653723,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":0.2990981094374136,"shares":28146154,"dividePrice":0,"high":29.52,"amplitude":0.032285,"preClose":29.58,"low":28.565,"week52Low":16.28,"pbRate":"4.25","week52High":38.93,"institutionHeld":0,"latestPrice":29,"eps":-1.769251,"divideRate":0,"volume":156505,"delay":0,"ttmEps":-1.769251,"open":28.8,"prevYearClose":28.87,"prevWeekClose":31.96,"prevMonthClose":29.2,"prevQuarterClose":25.71,"fiveDayClose":31.96,"twentyDayClose":27.34,"sixtyDayClose":25.52},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541841138","title":"Lightstone Ventures, Temasek’s ClavystBio co-lead Allay Therapeutics’ US$57.5 million Series D funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2541841138","media":"businesstimes","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541841138?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:19","pubTimestamp":1749154763,"startTime":"0","endTime":"0","summary":"The company’s technology is used to create analgesic products that can aid patients with post-surgical pain management and recuperation","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/startups-tech/startups/lightstone-ventures-temaseks-clavystbio-co-lead-allay-therapeutics-us57-5-million-series-d-funding","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/startups-tech/startups/lightstone-ventures-temaseks-clavystbio-co-lead-allay-therapeutics-us57-5-million-series-d-funding","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["LU1093756325.SGD","LU0109394709.USD","LU1430594728.SGD","SG9999013999.USD","VERX","LU2236285917.USD","VRTX","LU0320765992.SGD","LU2324357040.USD","BK4539","LENZ","LU0058720904.USD","LU0566484027.USD","LU1674673691.USD","LU0256863811.USD","IE00BJT1NW94.SGD","BK4007","SG9999001176.SGD","IE00B4R5TH58.HKD","LU1778281490.HKD","SGXZ57979304.SGD","BK4023","LU2362540622.SGD","IE00B894F039.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0757428866.USD","IE00B19Z9Z06.USD","LU1815336091.USD","LU2456880835.USD","IE00BZ199S13.USD","BK4124","IE00B19Z9P08.USD","IE0002270589.USD","LU2417539215.USD","VC","IE0009355771.USD","IE00B19Z3B42.SGD","IE00BJJMRZ35.SGD","LU0289739699.SGD","BK4588","LU1674673428.USD","LU0061475181.USD","SG9999001176.USD","LU1069344957.HKD","LU1559883803.SGD","LU0823416689.USD","LU2462157665.USD","LU2237438978.USD"],"gpt_icon":0},{"id":"2541589003","title":"Actuate Therapeutics Hosts Key Opinion Leader Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2541589003","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541589003?lang=en_us&edition=fundamental","pubTime":"2025-06-06 03:17","pubTimestamp":1749151057,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics, Inc. ( ($ACTU) ) just unveiled an announcement. On May 31, 2025, Actuate Therapeutics hosted a Key Opinion Leader event to di...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actuate-therapeutics-hosts-key-opinion-leader-event?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actuate-therapeutics-hosts-key-opinion-leader-event?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539","ACTU"],"gpt_icon":0},{"id":"2541070669","title":"Crispr Therapeutics call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2541070669","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541070669?lang=en_us&edition=fundamental","pubTime":"2025-06-06 01:25","pubTimestamp":1749144318,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Crispr Therapeutics (CRSP) with 6,908 calls trading, 3x expected, and implied vol increasing almost 4 points to 63....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/crispr-therapeutics-call-volume-above-normal-and-directionally-bullish-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/crispr-therapeutics-call-volume-above-normal-and-directionally-bullish-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRSP","BK4539","BK4585","LENZ","BK4588","BK4556","BK4007","LU1861558580.USD","LU1861559042.SGD","BK4611","BK4139"],"gpt_icon":0},{"id":"2541076282","title":"Edgewise Therapeutics Price Target Maintained With a $48.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2541076282","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541076282?lang=en_us&edition=fundamental","pubTime":"2025-06-05 22:16","pubTimestamp":1749132960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EWTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 05, 2025 10:16 ET (14:16 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX","LENZ"],"gpt_icon":0},{"id":"2541020435","title":"Kazia Therapeutics says first patient dosed in Phase 1b Trial of paxalisib","url":"https://stock-news.laohu8.com/highlight/detail?id=2541020435","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541020435?lang=en_us&edition=fundamental","pubTime":"2025-06-05 20:10","pubTimestamp":1749125442,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics (KZIA) announced that the first patient has been dosed in a Phase 1b clinical trial sponsored by Kazia. The study evaluates paxa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kazia-therapeutics-says-first-patient-dosed-in-phase-1b-trial-of-paxalisib-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kazia-therapeutics-says-first-patient-dosed-in-phase-1b-trial-of-paxalisib-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","KZIA","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2541221830","title":"Atossa Therapeutics initiated with a Buy at Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2541221830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541221830?lang=en_us&edition=fundamental","pubTime":"2025-06-05 19:15","pubTimestamp":1749122125,"startTime":"0","endTime":"0","summary":"Craig-Hallum initiated coverage of Atossa Therapeutics (ATOS) with a Buy rating and $4 price target Published first on TheFly – the ultimate source...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atossa-therapeutics-initiated-with-a-buy-at-craig-hallum-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atossa-therapeutics-initiated-with-a-buy-at-craig-hallum-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","ATOS","LENZ","BK4539"],"gpt_icon":0},{"id":"2541023516","title":"Cutia Therapeutics Successfully Passes All Resolutions at AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2541023516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541023516?lang=en_us&edition=fundamental","pubTime":"2025-06-05 17:14","pubTimestamp":1749114869,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics ( ($HK:2487) ) has issued an announcement. Cutia Therapeutics held its Annual General Meeting on June 5, 2025, where all propose...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cutia-therapeutics-successfully-passes-all-resolutions-at-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cutia-therapeutics-successfully-passes-all-resolutions-at-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","LENZ","AGM","BK4195","BK4007","BK4229"],"gpt_icon":0},{"id":"2541434820","title":"Chimeric Therapeutics Receives US FDA Fast Track Designation for CHM CDH17 CAR-T Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2541434820","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541434820?lang=en_us&edition=fundamental","pubTime":"2025-06-05 14:00","pubTimestamp":1749103219,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics (ASX:CHM) said that the US Food and Drug Administration (FDA) granted fast-track designation to its CHM CDH17 chimeric antigen receptor T-cell (CAR-T) therapy for treating advanc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4022","BK4539","CHM.AU","BK4567","BK4230","CAR","IE00B5TLWC47.USD","IE00BYQQ9H92.USD","BK4139","BK4585","IE00BFXG0V08.USD","FAST","BK4007","BK7067","BK4104","BK4588","LENZ"],"gpt_icon":0},{"id":"2541048751","title":"Addex Therapeutics Advances GABAB PAM Program for Chronic Cough","url":"https://stock-news.laohu8.com/highlight/detail?id=2541048751","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541048751?lang=en_us&edition=fundamental","pubTime":"2025-06-05 13:32","pubTimestamp":1749101551,"startTime":"0","endTime":"0","summary":"Addex Therapeutics ( ($CH:ADXN) ) just unveiled an announcement. Addex Therapeutics announced that preclinical data from its GABAB positive alloste...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/addex-therapeutics-advances-gabab-pam-program-for-chronic-cough?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/addex-therapeutics-advances-gabab-pam-program-for-chronic-cough?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4081","PAM","BK4563","BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2541010394","title":"Promising Developments in Mersana Therapeutics’ Emi-Le Program Bolster Positive Outlook for TNBC Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2541010394","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541010394?lang=en_us&edition=fundamental","pubTime":"2025-06-05 12:25","pubTimestamp":1749097548,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Jonathan Chang has reiterated their bullish stance on MRSN stock, giving a Buy rating on June 3. Jonathan Chang’s rating i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-in-mersana-therapeutics-emi-le-program-bolster-positive-outlook-for-tnbc-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-in-mersana-therapeutics-emi-le-program-bolster-positive-outlook-for-tnbc-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2541017860","title":"Marker Therapeutics Reports Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2541017860","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541017860?lang=en_us&edition=fundamental","pubTime":"2025-06-05 11:51","pubTimestamp":1749095508,"startTime":"0","endTime":"0","summary":"Marker Therapeutics ( ($MRKR) ) has released its Q1 earnings. Here is a breakdown of the information Marker Therapeutics presented to its investors...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/marker-therapeutics-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/marker-therapeutics-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2541091373","title":"Trevi Therapeutics Announces Public Offering Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2541091373","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541091373?lang=en_us&edition=fundamental","pubTime":"2025-06-05 04:51","pubTimestamp":1749070309,"startTime":"0","endTime":"0","summary":"Trevi Therapeutics ( ($TRVI) ) has issued an update. On June 3, 2025, Trevi Therapeutics announced the pricing of its underwritten public offering ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/trevi-therapeutics-announces-public-offering-pricing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/trevi-therapeutics-announces-public-offering-pricing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2540282061","title":"ADC Therapeutics falls -4.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540282061","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540282061?lang=en_us&edition=fundamental","pubTime":"2025-06-04 21:50","pubTimestamp":1749045032,"startTime":"0","endTime":"0","summary":"ADC Therapeutics (ADCT) is down -4.5%, or -16c to $3.43. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-falls-4-5-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-falls-4-5-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","LENZ","BK4505","BK4080","ADC","ADCT","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2540065578","title":"BriaCell Therapeutics Schedules Virtual Investor Presentations for June 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2540065578","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540065578?lang=en_us&edition=fundamental","pubTime":"2025-06-04 20:14","pubTimestamp":1749039285,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics ( ($TSE:BCT) ) has provided an update. BriaCell Therapeutics Corp. announced that it will conduct two virtual investor presen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-schedules-virtual-investor-presentations-for-june-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-schedules-virtual-investor-presentations-for-june-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BCTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2541095873","title":"Allarity Therapeutics Announces Research Collaboration with Indiana Biosciences Research Institute to Further Advance Understanding of Stenoparib’s Unique, Dual Therapeutic Mechanism of Action","url":"https://stock-news.laohu8.com/highlight/detail?id=2541095873","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541095873?lang=en_us&edition=fundamental","pubTime":"2025-06-04 20:00","pubTimestamp":1749038400,"startTime":"0","endTime":"0","summary":"TARPON SPRINGS, Fla., June 4, 2025 -- Allarity Therapeutics, Inc.  , a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as a personalized cancer treatment using its proprietary, drug-specific Drug Response Predictor  patient selection technology—today announced a research collaboration with the Indiana Biosciences Research Institute . The collaboration is aimed primarily at further deepening the Company’s mechanistic understanding of the dual mechanism of action of stenoparib.Furthermore, this collaboration underscores Allarity’s commitment to scientific excellence, translational research, and data-driven development, which form the foundation of its personalized oncology strategy.About The Indiana Biosciences Research Institute The Indiana Biosciences Research Institute  is a leading translational research institute that accelerates innovation by bridging academic and industry science through collabo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allarity-therapeutics-announces-research-collaboration-120000202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4007","ALLR","BK4139","LENZ"],"gpt_icon":0},{"id":"2540063189","title":"Quince Therapeutics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2540063189","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540063189?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:58","pubTimestamp":1749038280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QNCX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 04, 2025 07:58 ET (11:58 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","QNCX"],"gpt_icon":0},{"id":"2540068561","title":"Design Therapeutics announces first FA patient dosed in RESTORE-FA trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2540068561","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540068561?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:10","pubTimestamp":1749035428,"startTime":"0","endTime":"0","summary":"Design Therapeutics (DSGN) announced that the first Friedreich ataxia, FA, patient has been dosed via intravenous infusion in its RESTORE-FA open-l...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/design-therapeutics-announces-first-fa-patient-dosed-in-restore-fa-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/design-therapeutics-announces-first-fa-patient-dosed-in-restore-fa-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","FA","BK4505","BK4130","BK4535","BK4139","DSGN","BK4007"],"gpt_icon":0},{"id":"2540305559","title":"Buy Recommendation for Candel Therapeutics: Promising Data on CAN-2409 Treatment for Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2540305559","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540305559?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:15","pubTimestamp":1749028552,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Candel Therapeutics (CADL – Research Report) yesterday and set a price...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-recommendation-for-candel-therapeutics-promising-data-on-can-2409-treatment-for-prostate-cancer-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-recommendation-for-candel-therapeutics-promising-data-on-can-2409-treatment-for-prostate-cancer-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0306806265.USD","LU0648001328.SGD","LU2129689431.USD","IE00B19Z3B42.SGD","BK4170","LU0306807586.USD","LU0106831901.USD","BK4207","IE0002270589.USD","LU0320765646.SGD","LU0683600562.USD","LU1162221912.USD","BK4534","CADL","LU1201861165.SGD","LU1496350502.SGD","BK4007","BK4553","CAN","LU0971096721.USD","LU1791807156.HKD","LU1894683348.USD","LU1363072403.SGD","LU1506573853.SGD","LU0234572021.USD","LENZ","LU1366192091.USD","LU0052756011.USD","BK4526","BK4585","LU0787776722.HKD","LU1280957306.USD","LU2129689605.HKD","LU0130103400.USD","IE00BLSP4239.USD","LU1718418525.SGD","BAC","LU0256863811.USD","LU1880398471.USD","IE00B19Z3581.USD","BK4139","BK4600","IE00BBT3K403.USD","LU0477156797.USD","LU0128525689.USD","BK4559","LU0321505868.SGD","LU0417517546.SGD","LU0314106906.USD","BK4504"],"gpt_icon":0},{"id":"2540032678","title":"EXACT Therapeutics to Hold Separate Board Candidate Votes at AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2540032678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540032678?lang=en_us&edition=fundamental","pubTime":"2025-06-04 15:32","pubTimestamp":1749022375,"startTime":"0","endTime":"0","summary":"EXACT Therapeutics AS ( ($DE:56F) ) just unveiled an update. EXACT Therapeutics AS announced that during their upcoming Annual General Meeting, sep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/exact-therapeutics-to-hold-separate-board-candidate-votes-at-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/exact-therapeutics-to-hold-separate-board-candidate-votes-at-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","BK4539","LENZ","BK4229","AGM","BK4195"],"gpt_icon":0},{"id":"2540363370","title":"IRLAB Therapeutics to Present at Aktiedagarna Event in Stockholm","url":"https://stock-news.laohu8.com/highlight/detail?id=2540363370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540363370?lang=en_us&edition=fundamental","pubTime":"2025-06-04 13:33","pubTimestamp":1749015185,"startTime":"0","endTime":"0","summary":"IRLAB Therapeutics AB Class A ( ($SE:IRLAB.A) ) has issued an announcement. IRLAB Therapeutics AB announced its participation in the Aktiedagarna e...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/irlab-therapeutics-to-present-at-aktiedagarna-event-in-stockholm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/irlab-therapeutics-to-present-at-aktiedagarna-event-in-stockholm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","BK4139","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":7,"totalSize":203,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-06-13","current":-17.439532,"percent":0.017422,"low":-18.842712,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"high":-5.069183,"avg":-10.841843,"sd":3.694257,"marketCap":832563235},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235}],"updateTime":1749979609838}}}